Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Intangibles (2016 - 2025)

Historic Intangibles for Haemonetics (HAE) over the last 16 years, with Q4 2025 value amounting to $419.7 million.

  • Haemonetics' Intangibles fell 985.38% to $419.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $419.7 million, marking a year-over-year decrease of 985.38%. This contributed to the annual value of $455.7 million for FY2025, which is 1221.96% up from last year.
  • Haemonetics' Intangibles amounted to $419.7 million in Q4 2025, which was down 985.38% from $428.4 million recorded in Q3 2025.
  • In the past 5 years, Haemonetics' Intangibles registered a high of $494.9 million during Q2 2024, and its lowest value of $250.5 million during Q3 2023.
  • For the 5-year period, Haemonetics' Intangibles averaged around $370.1 million, with its median value being $359.6 million (2021).
  • Its Intangibles has fluctuated over the past 5 years, first soared by 17458.04% in 2021, then tumbled by 1510.93% in 2022.
  • Haemonetics' Intangibles (Quarter) stood at $337.2 million in 2021, then fell by 15.68% to $284.4 million in 2022, then soared by 50.95% to $429.3 million in 2023, then rose by 8.47% to $465.6 million in 2024, then decreased by 9.85% to $419.7 million in 2025.
  • Its last three reported values are $419.7 million in Q4 2025, $428.4 million for Q3 2025, and $450.6 million during Q2 2025.